Atlas market file · Etf · United States
John Hancock Core Plus Bond ETFJHCP
- Last close
- 24.77
- Change
- -0.24%
- 96-bar range
- 24.63 – 25.47
- As of
- 10 Aug 2026
John Hancock Core Plus Bond ETF is an exchange-traded fund listed as JHCP on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 87 weekly closes (-0.07% over the window).
Source rail: Yahoo Finance chart API (JHCP). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for JHCP. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
JHCP public profile
Exchange-traded fund. John Hancock Core Plus Bond ETF is connected to current market context, cited company sources and its retained research file.
John Hancock Core Plus Bond ETF trades as JHCP on AMEX. John Hancock Core Plus Bond ETF (JHCP) has a latest verified close of 24.77, down 0.24%, dated 10 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. JHCP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for John Hancock Core Plus Bond ETF today
John Hancock’s Core Plus Bond ETF, ticker JHCP, is a Nasdaq-listed wrapper that promises investors managed exposure to a diversified basket of investment-grade and below-investment-grade bonds without the hassle of individual bond selection. The fund’s existence is formally documented by the Securities and Exchange Commission via an EDGAR search entry, which confirms its registration but provides no visibility into its holdings, performance, or fee schedule within the search results themselves. The ticker’s presence on Nasdaq confirms it has a market quote endpoint, yet the page offers no liquidity metrics, bid-ask spreads, or volume history-leaving investors to infer liquidity from the wrapper’s own marketing materials rather than the exchange data. (source: SEC EDGAR fund search for JHCP, https://www.sec.gov/edgar/search/#/q=JHCP; Nasdaq, https://www.nasdaq.com/market-activity/etf/jhcp)
The fund’s expense ratio is not disclosed in the Nasdaq quote or the SEC search entry; however, the issuer’s marketing language emphasizes “core plus” bond exposure, which typically implies a blend of investment-grade and high-return bonds managed within a defined duration band. The marketing gloss is not matched by the transparency of the wrapper: the SEC filing itself is the sole public source confirming the fund’s structure, while the actual holdings, fee schedule, and performance attribution are buried in periodic reports that are not accessible via the ticker page or the SEC search interface. The issuer’s pitch is therefore a promise delivered through filing trail, not through the market plumbing visible to end-investors. (source: SEC EDGAR fund search for JHCP, https://www.sec.gov/edgar/search/#/q=JHCP)
The FINRA Fund Analyzer tool provides a second layer of disclosure by allowing investors to input the ticker and retrieve fee and risk metrics, but the results are only as transparent as the fund’s own filings. The Analyzer does not validate the fund’s investment thesis or its actual holdings; it merely confirms the fee structure and basic risk labels. The issuer’s “core plus” theme is therefore tested against a fee that is both visible and unavoidable, while the underlying portfolio’s construction remains opaque to all but the most diligent filers. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
For readers seeking a chart route, the Nasdaq page for JHCP includes a TradingView embed that displays intraday price action and a basic price chart, but the evidence does not supply any specific levels, volumes, or trend context beyond the live feed. The chart is therefore a mirror of the ticker’s activity, not a source of independent insight. The fund’s liquidity profile-whether it trades like a major ETF or a niche sleeve-cannot be inferred from the chart alone without additional volume and spread data. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/jhcp)
The evidence does not include any periodic filings, holdings disclosures, or performance data for JHCP, so the fund’s actual yield, duration, credit quality mix, and turnover remain unproven in this report. The only concrete facts are the fund’s registration on SEC EDGAR, its ticker’s presence on Nasdaq, and the issuer’s marketing language as communicated through the exchange’s quote page. Without the fund’s N-PORT or N-CEN filings, investors are left to trust the wrapper’s theme rather than verify the portfolio’s substance. The distance between the marketing and the market data is the distance between the slide and the spreadsheet. (source: SEC EDGAR fund search for JHCP, https://www.sec.gov/edgar/search/#/q=JHCP; Nasdaq, https://www.nasdaq.com/market-activity/etf/jhcp)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
JHCP technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on JHCP
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep JHCP research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
JHCP FAQ
What is John Hancock Core Plus Bond ETF (JHCP)?John Hancock Core Plus Bond ETF (JHCP) has a latest verified close of 24.77, down 0.24%, dated 10 Aug 2026. Use this page to check the price chart, company context,...
John Hancock Core Plus Bond ETF (JHCP) has a latest verified close of 24.77, down 0.24%, dated 10 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for JHCP?John Hancock Core Plus Bond ETF (JHCP) has a latest verified close of 24.77, down 0.24%, dated 10 Aug 2026. It brings the latest available chart, company context, cited...
John Hancock Core Plus Bond ETF (JHCP) has a latest verified close of 24.77, down 0.24%, dated 10 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. JHCP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the JHCP page updated?The JHCP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The JHCP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for JHCP?The JHCP file starts with Nasdaq Trader and TradingView AMEX:JHCP. The page separates verified market context from company evidence and shows open evidence gaps instead...
The JHCP file starts with Nasdaq Trader and TradingView AMEX:JHCP. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on JHCP?Yes. The workstation can open JHCP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open JHCP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this JHCP page investment advice?No. The JHCP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The JHCP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
JHCP
Etf · evidence first